FDA Inspection 1227337 — The Northeast Philadelphia Donor Center American Red Cross Penn Jersey Region Biomedical Services
The FDA completed an inspection of The Northeast Philadelphia Donor Center American Red Cross Penn Jersey Region Biomedical Services on December 5, 2023 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 5, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Philadelphia, PA (United States)